PMID- 37768525
OWN - NLM
STAT- MEDLINE
DCOM- 20240304
LR  - 20240304
IS  - 1720-8386 (Electronic)
IS  - 0391-4097 (Linking)
VI  - 47
IP  - 3
DP  - 2024 Mar
TI  - Associations between abdominal obesity indices with hypertension in type 2 
      diabetes mellitus: Chinese visceral adiposity index.
PG  - 547-555
LID - 10.1007/s40618-023-02165-6 [doi]
AB  - PURPOSE: This research was performed to evaluate the relationship between 
      hypertension (HTN) and abdominal obesity index in patients with type 2 diabetes 
      mellitus (T2DM). METHODS: Totally 1657 participants with T2DM (mean age 
      54 +/- 12 years; 38.02% female) were enrolled. They were divided into the groups of 
      HTN (n = 775) and non-HTN (n = 882). Anthropometric and biochemical indicators 
      were measured and collected. A bioelectrical impedance analyzer was used to 
      measure visceral and subcutaneous fat areas. RESULTS: Compared with the HTN 
      group, the non-HTN group had a lower level of Chinese visceral adiposity index 
      (CVAI) (p < 0.001). Meanwhile, among tertiles of CVAI, as CVAI increased, the 
      proportion of patients with HTN increased, which was 33.51%, 44.30%, and 62.50%, 
      respectively. CVAI was shown to have a significant positive correlation with HTN. 
      (r = 0.258, p < 0.001). CVAI was independently related to an elevated risk of HTN 
      by binary logistic regression analyses, and the OR was (95% CI) 1.013 
      (1.010-1.016, p < 0.001) after adjustment. The area under the receiver operating 
      characteristic curve (AUC) of CVAI predicted HTN in T2DM patients was greater 
      than those of other abdominal obesity indices (p < 0.001). CONCLUSION: We found 
      that CVAI was highly positively correlated with HTN in T2DM. Compared with other 
      indices of abdominal obesity, such as WC, BMI, WHR, VAI, and LAP, the CVAI showed 
      superior discriminative ability in T2DM complicated with HTN. Therefore, more 
      attention should be paid to CVAI in T2DM.
CI  - (c) 2023. The Author(s), under exclusive licence to Italian Society of 
      Endocrinology (SIE).
FAU - Cheng, C
AU  - Cheng C
AUID- ORCID: 0000-0002-3896-1988
AD  - Department of Endocrinology and Metabolism, Affiliated Hospital of Jiangsu 
      University, Institute of Endocrine and Metabolic Diseases, Jiangsu University, 
      Zhenjiang, China.
FAU - Yu, X
AU  - Yu X
AD  - Department of Endocrinology and Metabolism, Affiliated Hospital of Jiangsu 
      University, Institute of Endocrine and Metabolic Diseases, Jiangsu University, 
      Zhenjiang, China.
FAU - Shi, K
AU  - Shi K
AD  - Department of Endocrinology and Metabolism, Affiliated Hospital of Jiangsu 
      University, Institute of Endocrine and Metabolic Diseases, Jiangsu University, 
      Zhenjiang, China.
FAU - Dai, G
AU  - Dai G
AD  - Department of Endocrinology and Metabolism, Affiliated Hospital of Jiangsu 
      University, Institute of Endocrine and Metabolic Diseases, Jiangsu University, 
      Zhenjiang, China.
FAU - Pan, Q
AU  - Pan Q
AD  - Department of Endocrinology and Metabolism, Affiliated Hospital of Jiangsu 
      University, Institute of Endocrine and Metabolic Diseases, Jiangsu University, 
      Zhenjiang, China.
FAU - Yuan, G
AU  - Yuan G
AD  - Department of Endocrinology and Metabolism, Affiliated Hospital of Jiangsu 
      University, Institute of Endocrine and Metabolic Diseases, Jiangsu University, 
      Zhenjiang, China. yuanguoyue@ujs.edu.cn.
FAU - Jia, J
AU  - Jia J
AD  - Department of Endocrinology and Metabolism, Affiliated Hospital of Jiangsu 
      University, Institute of Endocrine and Metabolic Diseases, Jiangsu University, 
      Zhenjiang, China. xibeizijj@aliyun.com.
LA  - eng
PT  - Journal Article
DEP - 20230928
PL  - Italy
TA  - J Endocrinol Invest
JT  - Journal of endocrinological investigation
JID - 7806594
SB  - IM
MH  - Humans
MH  - Female
MH  - Adult
MH  - Middle Aged
MH  - Aged
MH  - Male
MH  - *Diabetes Mellitus, Type 2
MH  - Obesity, Abdominal/complications/diagnosis
MH  - Adiposity
MH  - Body Mass Index
MH  - Obesity/complications
MH  - *Hypertension/complications/diagnosis/epidemiology
MH  - *Obesity, Morbid/complications
MH  - China/epidemiology
OTO - NOTNLM
OT  - Abdominal obesity index
OT  - Chinese visceral adiposity index
OT  - Hypertension
OT  - Type 2 diabetes mellitus
EDAT- 2023/09/28 12:45
MHDA- 2024/03/04 06:50
CRDT- 2023/09/28 11:15
PHST- 2023/02/08 00:00 [received]
PHST- 2023/07/14 00:00 [accepted]
PHST- 2024/03/04 06:50 [medline]
PHST- 2023/09/28 12:45 [pubmed]
PHST- 2023/09/28 11:15 [entrez]
AID - 10.1007/s40618-023-02165-6 [pii]
AID - 10.1007/s40618-023-02165-6 [doi]
PST - ppublish
SO  - J Endocrinol Invest. 2024 Mar;47(3):547-555. doi: 10.1007/s40618-023-02165-6. 
      Epub 2023 Sep 28.